top of page
Flowers for Sale_edited.jpg

Organizations We Support

Four years ago, we were unfamiliar with the range of activities and organizations operating in the ALS community. That changed when we began to work with the MGH Healey Center and their multidisciplinary clinic in Boston. They were critical in our early journey by helping us with a range of services, beginning with the very first conversations we had together with our family members.

​

Our mission going forward is to continue to identify and support organizations that support ALS patients and their families. Statistically, there is a new ALS diagnosis every 90 minutes, while another person dies from ALS every 90 minutes. We want to make our contribution to those yet to be diagnosed, so that we can eventually end this disease which exacts such a difficult toll on individuals and families confronting ALS. 

​

Is there an organization we should take a look at? Please share it with us.

Our first grant

On February 15, 2024, The Debra M. Williams ALS Fund made its first grant to the UMass Chan Medical School. We are excited about their commitment to C9orf72 therapy development and look forward to continuing to partner with them in the years ahead.  

​

Learn more about UMass Chan Medical School's work in the RNA Therapeutics Institute.

Types of organizations we have supported

Care & Support

Throughout our journey with ALS, we were introduced to accessibility architects, equipment suppliers, communications augmentation specialists, physicians, palliative care professionals, therapists, and research scientists. We have supported these organizations through our annual financial gifts and by making in-kind donations of equipment that supported ALS loaner networks. 

Therapy Development

We also became acquainted with the range and complexity of research targeting new therapies, from organizations like ALS TDI to the many medical centers working in concert with a range of life sciences companies. We are particularly interested in work surrounding the C9orf72 gene mutation, a rare but identifiable sub-category in ALS that can facilitate more longitudinal studies of ALS disease progression. 

We want your help

Do you have any organizations we should add to our list? Let us know! We'd love to hear from you.

bottom of page